Navigation Links
Human Genome Sciences Presents New Data Showing Anti-Tumor Activity And Safety Of Trail Receptor Antibodies In Combination With Chemotherapy
Date:10/24/2007

nts within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements are based on Human Genome Sciences' current intent, belief and expectations. These statements are not guarantees of future performance and are subject to certain risks and uncertainties that are difficult to predict. Actual results may differ materially from these forward-looking statements because of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing of clinical trials, the Company's ability to develop and commercialize products, its dependence on collaborators for services and revenue, its substantial indebtedness and lease obligations, its changing requirements and costs associated with facilities, intense competition, the uncertainty of patent and intellectual property protection, the Company's dependence on key management and key suppliers, the uncertainty of regulation of products, the impact of future alliances or transactions and other risks described in the Company's filings with the Securities and Exchange Commission. In addition, the Company will continue to face risks related to animal and human testing, to the manufacture of ABthrax and to FDA concurrence that ABthrax meets the requirements of the ABthrax contract. If the Company is unable to meet the product requirements associated with the ABthrax contract, the U.S. government will not be required to reimburse the Company for the costs incurred or to purchase any ABthrax doses. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date. Human Genome Sciences undertakes no obligation to update or revise the information contained in this announcement whether as a result of new information, future events or circumstances or otherwise.


'/>"/>
SOURCE Human Genome Sciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Testing for Human Papillomavirus
2. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
3. Phase II Results Show Once-Daily Dosing of Human GLP-1 Analog Liraglutide, Brings Patients to A1c Target
4. Apollos human proteins boost stem cell research
5. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
6. Modigene Announces Successful Completion of Pharmacokinetic & Pharmacodynamic Pre-Clinical Experiments for Proprietary Long-Acting Human Growth Hormone, Long-acting Interferon Beta and Long-acting Erythropoietin
7. Second Successful Quigley QR-443 Study Suggests Method of Action Relevant to Broad Range of Chronic Inflammatory Diseases - Human Study to Follow -
8. Research Documents Scalable Production, Survival Following Engraftment and Positive Impact on Cardiac Function in Infarcted Rats for Gerons Human Embryonic Stem Cell-Based Therapeutic for Heart Failure
9. Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B Showed Significant Reductions in Disease Activity in Patients with Active Systemic Lupus Erythematosus
10. NCI Researchers Discover Genes That Are Turned on at High Levels in Tumor-associated Blood Vessels of Mice and Humans
11. Research Indicates Gerons Human Embryonic Stem Cell-Based Therapeutic for Spinal Cord Injury Evades Direct Attack by the Human Immune System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Md. , Aug. 29, 2014  United Therapeutics ... the U.S. District Court for the District of ... favor in the company,s case against Sandoz, Inc. regarding ... Peter Sheridan ruled that U.S. Patent No. ... and enjoined Sandoz from marketing its generic product until ...
(Date:8/29/2014)... , Aug. 29, 2014 Diseases largely ... a generation ago are returning. Measles was declared eliminated ... in 2014 as of August 15—the highest incidence in ... public health department declared whooping cough a problem of ... are getting sick and dying from these preventable diseases—in ...
(Date:8/29/2014)... Research and Markets has announced the addition ... report to their offering. Multiple ... in demyelination, axonal transection, and neurodegeneration. The myelin sheath ... immune system, which targets neurons within the central nervous ... which the damage of the myelin sheath causes disruption ...
Breaking Medicine Technology:District Court Decision Received In Remodulin Patent Case 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 2Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 3
... CHATTANOOGA, Tenn., Feb. 28, 2011 Glenveigh Medical, LLC ... exclusive distribution rights in the United States as well ... AN24 wireless fetal monitoring system. The system recently received ... Marketed under the trade name Beacon by Monica™ ...
... Bacterin International Holdings, Inc. ("Bacterin") (OTC Bulletin Board: ... material, today announced that its recently launched OsteoSponge®SC, a ... used by a high volume orthopedic institution, Arkansas Surgical ... in N Little Rock, AR, opened in 2005, is ...
Cached Medicine Technology:Glenveigh Medical and Monica Healthcare Announce Distribution Agreement for Groundbreaking FDA Cleared Wireless Fetal Monitoring System 2Bacterin International Announces Major Orthopedic Hospital Group to Begin Use of OsteoSponge®SC 2Bacterin International Announces Major Orthopedic Hospital Group to Begin Use of OsteoSponge®SC 3
(Date:8/29/2014)... August 30, 2014 Developed as a ... high quality Canada Goose products offer the ... working on Arctic runways. The company’s Canada Goose ... in the current market. Additionally, the firm has unveiled ... offer. , At present, all high quality Chilliwack ...
(Date:8/29/2014)... According to a CNN article, entitled ... (8/25), a new study found that those states who ... a significant decrease in the number of painkiller overdoses ... year period, and comparing various states with and without ... there was about a 25% decrease in painkiller prescription ...
(Date:8/29/2014)... As reported by CNN.com in the article Prescription ... admitting that you need help for a prescription drug abuse ... the fact that if you simply try to find general ... all of the information that is available online. Although the ... is still possible to get help. The statistics from SAMSHA ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 According to new ... But Not Peer Pressure, Key to Prescription Drug Misuse Among ... primary focus for 18-29 year olds when it comes to ... the for this age group the real problem which influences ... drug associations and recreational use of them to have fun ...
(Date:8/29/2014)... article entitled How Genes, Gender and Environment Influence Substance ... gender and the environment that an individual is in affect ... Indiana University are taking another look at the fact that ... this factor to what is known about the influences of ... ties can help to reduce a man’s risk for abusing ...
Breaking Medicine News(10 mins):Health News:New Designs Of Canada Goose Chilliwack Bombers From DoudouneCanadienneGoosePasCher.fr 2Health News:Overdoses on Painkillers Decreased in States With Medical Marijuana 2Health News:Overdoses on Painkillers Decreased in States With Medical Marijuana 3Health News:What to Know When Seeking Drug Addiction Help 2Health News:What to Know When Seeking Drug Addiction Help 3Health News:Peer Pressure Irrelevant in Prescription Drug Abuse for Young Adults 2Health News:Peer Pressure Irrelevant in Prescription Drug Abuse for Young Adults 3Health News:Substance Abuse Likelihood Affected by Environment, Gender and Genes 2Health News:Substance Abuse Likelihood Affected by Environment, Gender and Genes 3
... converging in patient care at a faster pace than ... point-of-care health technologies like telemedicine to medical robots performing ... What,s next? Ask NJIT Distinguished Professor Atam Dhawan, ... Albert Dorman Honors College, chair of the the ...
... is available in German . Protein deposits in ... alteration of the tau protein through the addition of phosphate groups ... the cells to aggregate into clumps. As a result, nerve cells ... plays an important role in learning and memory, as well as ...
... EAST LANSING, Mich. For the first time, ... for migraine sufferers, a finding that could help ... ailment. Jie Huang of Michigan State ... imaging, or fMRI, to reveal how precision-tinted lenses ...
... , THURSDAY, May 26 (HealthDay News) -- College ... are bigger and faster than the rest, according to new ... of the Journal of Strength and Conditioning Research , ... players who were "highly recruited" by college scouts were height, ...
... 26, 2011Young adults ages 19-29 are struggling to get the ... group, demonstrating the need for Affordable Care Act provisions, some ... it more affordable, according to a new Commonwealth Fund report. ... adults couldn,t afford the care they needed, meaning they didn,t ...
... of researching traumatic stress with war-afflicted populations (veterans and ... McIntyre, a research professor in the department of psychology ... (TIMES), at the University of Houston (UH), decided to ... seventh and eighth grade. "Teaching is a ...
Cached Medicine News:Health News:5 new hot spots where medicine and technology will converge 2Health News:Stress may increase risk for Alzheimer's disease 2Health News:Precision-tinted lenses offer real migraine relief, reveals new study 2Health News:Speed, Size Predict Teen Football Players' Rankings 2Health News:Health reform essential to young adults: Nearly half can't afford needed health care 2Health News:Health reform essential to young adults: Nearly half can't afford needed health care 3Health News:Health reform essential to young adults: Nearly half can't afford needed health care 4Health News:New University of Houston research study links job stress in teachers to student achievement 2Health News:New University of Houston research study links job stress in teachers to student achievement 3
... its wide orifice tip, the Finntip Wide ... suspensions and macromolecules like genomic DNA. This ... cell fragmentation. It is excellent for use ... model, the inside diameter of the orifice ...
300 L, Racked, 96 tips/rack Recommended for 250 and 300 L pipettes....
... Application: Pipette tips in a ... Product features of Autoclavable Racks: ... C, Tips supplied in racks with ... Each row of tips is specifically ...
RNase-free Tips...
Medicine Products: